Stock Comparison
ABBV vs AMGN
AbbVie Inc and Amgen Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$439.97B
$222.66B
P/E (TTM)
70.3
25.6
Forward P/E
17.7
18.4
Price/Sales
6.8
5.9
Price/Book
51.1
19.1
EV/EBITDA
25.8
15.1
Dividend Yield
2.03%
2.35%
Profitability
Net Margin
9.82%
20.95%
Operating Margin
29.77%
31.63%
Return on Equity
62.30%
91.50%
Return on Assets
10.50%
8.67%
Growth (YoY)
Revenue Growth
10.20%
9.50%
Earnings Growth
290.40%
64.90%
Price & Risk
Beta
0.3
0.4
52-Week High
$263.65
$417.84
52-Week Low
$197.38
$265.41
Analyst Target
$274.36
$374.69
Compare ABBV and AMGN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.